Published on 3 Jan 2024 on Simply Wall St. via Yahoo Finance
AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 99% Above Its Share Price
Key Insights
AtriCure's estimated fair value is US$70.42 based on 2 Stage Free Cash Flow to EquityCurrent share price of US$35.32 suggests AtriCure is potentially 50% undervalued The US$55.63 analyst price target for ATRC is 21% less than our estimate of fair value
In this article we are going to estimate the intrinsic value of AtriCure, Inc. (NASDAQ:ATRC) by taking the forecast future cash flows of the company and discounting them back to today's value. This will be done using the Discounted Cash Flow (DCF) model. Before you think you won't be able to understand it, just read on! It's actually much less complex than you'd imagine.